Eisai (Malaysia) Sdn Bhd

Formally established in 1941 and headquartered in Tokyo, Japan, Eisai has since grown to become a leading global research and development-based pharmaceutical company, operating over 40 subsidiaries and employing more than 10,000 employees worldwide. Its continued commitment to improving lives is grounded in rigorous scientific research and its human health care (hhc) philosophy, which emphasises the need for all its employees to spend 1% of their working hours with patients.

At Eisai, we apply our strengths to the fullest extent possible in providing solutions to various diseases. Eisai has positioned neurology (Alzheimer’s disease & epilepsy) and Oncology, as its therapeutic areas of expertise and focus. While many diseases for which adequate treatments have yet to be established in these areas, Eisai aspires to ensure that the fast-growing middle-income population in emerging markets has access to innovative medicine and science.

Eisai Malaysia celebrated its golden jubilee in 2019 to mark the corporation’s presence and growth in the country since 1969. Inspired by the history and expansion of its parent company in Japan, Eisai Malaysia continues to champion and advocate for universal access to innovative medicines.

“We give first thought to patients and their families, and to increasing the benefits health care providers”.

• Eisai's corporate philosophy reflects our commitment to business activities aiming to increase the benefits to patients, their families, and consumers, who we recognize as the key players in healthcare. This corporate philosophy is summarized by the term “human health care (hhc)”.
• Eisai Malaysia is steadfast in its commitment to being the pioneering hhc company in the nation, firm in the belief that the people’s health cannot be approached as a mere statistic, but as a holistic experience that is capable of transforming communities, beyond healing the individual patient.

Learn more about Eisai Malaysia and our hhc philosophy at https://eisaimal.com.my